Thymic Stromal Lymphopoietin (TSLP) in Vitiligo

study & verify the hypothesis of the involvement of TSLP in the pathogenesis of vitiligo in comparison to their levels in the healthy control persons.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Vitiligo Hypopigmentation Pigmentation Disorders Skin Diseases Skin and Connective Tissue Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

• Patients with generalized non-segmental vitiligo.

Both sexes.
Age < 18 years old age.
New cases or cases not receiving any medication for at least 3 months ago.

Exclusion criteria

• Age: Patients < 18 years.

Segmental or universal vitiligo.
Pregnant and lactating females. Autoimmune diseases

Treatment and study plan

Skin biopsy

Other

Lesional skin biopsy was taken from every patient. Also a skin biopsy was taken from every control subject

Primary outcomes

Expression levels of TSLP in patients of Vitiligo.

Time frame: 7 months

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Official study title

Study of the Cutaneous Expression of Thymic Stromal Lymphopoietin (TSLP) in a Sample of Vitiligo Patients

Important dates

Study start: 2017
Primary completion: 2017
Study completion: 2017
First posted: Dec 8, 2017
Registry last updated: Dec 20, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed